T. Rho

Design, synthesis, and neurochemical evaluation of 2-amino-5-(alkoxycarbonyl)-3,4,5,6-tetrahydropyridines and 2-amino-5-(alkoxycarbonyl)-1,4,5,6-tetrahydropyrimidines as M1 muscarinic receptor agonists.

D. A. Smith, P. Dunbar, G. J. Durant, 1994, Journal of medicinal chemistry.

Influence of some novel N-substituted azoles and pyridines on rat hepatic CYP3A activity.

T. Rho, J. Slama, L. Sambucetti, 1998, Biochemical pharmacology.

2-5A Ligands—A New Concept for the Treatment of Prostate Cancer

R. Silverman, James R Okicki, H. Cramer, 2007, Nucleosides, nucleotides & nucleic acids.

One-Pot Synthesis of Pyrimidine-5-Carboxaldehyde and Ethyl Pyrimidine-5-Carboxylate by Utilizing Pyrimidin-5-yl-Lithium

T. Rho, Y. F. Abuh, 1994 .

Synthesis, biochemical activity and behavioral effects of a series of 1,4,5,6-tetrahydropyrimidines as novel ligands for M1 receptors

W. Hoss, K. Ryan, P. Dunbar, 1992 .

Synthesis and biological characterization of 1,4,5,6-tetrahydropyrimidine and 2-amino-3,4,5,6-tetrahydropyridine derivatives as selective m1 agonists.

P. Dunbar, T. Rho, B. Ojo, 1997, Journal of medicinal chemistry.

The Synthesis of Radermachol

B. S. Joshi, T. Rho, S. Pelletier, 1994 .

The structure of the π-molecular complex between 1,4-dihydro-9,10-anthrahydroquinone and 1,4-dihydro-9,10-anthraquinone

B. S. Joshi, P. Rinaldi, T. Rho, 1991 .